Ubidecarenone 1384 views0 applications

Australian Approved Name (AAN): Ubidecarenone

Common name/s and synonyms: Co-Enzyme Q10; Ubidecarenone anhydrous

Molecular formula: C59H90O4

Molecular weight: 863.34

Maximum daily dose: 300mg

Warnings and Restrictions: When used as an excipient, the route of administration must be topical and the concentration in the medicine must not be more than 0.05%. Not to be included in medicines intended for use in the eye.

When for internal use, the maximum recommended daily dose must not provide more than 300 milligrams of ubidecarenone. When for internal use in combination with Ubiquinol-10, the maximum recommended daily dose must not provide more than 300 milligrams of ubiquinol-10 and ubidecarenone combined.

When for internal use, the following warning statement is required on the medicine label:
WARF – Do not take while on warfarin therapy without medical advice.

Allowable purpose of the ingredient: Active. Excipient

TGA reference: International Non-Proprietary Name

Apply for this resource
Share this resource